IgA nephropathy, also known as Berger's disease, is a common form of glomerulonephritis, a kidney disease. It is characterized by the deposition of immunoglobulin A (IgA) in the glomeruli, leading to inflammation and damage. The prevalence of IgA nephropathy varies across different populations, but it is estimated to affect around 1 in 1000 individuals worldwide. It is more prevalent in certain regions, such as Asia, where it is the most common primary glomerular disease. Early diagnosis and management are crucial to prevent progression to end-stage renal disease.
IgA nephropathy, also known as Berger's disease, is a common form of glomerulonephritis, which is a kidney disease characterized by inflammation of the glomeruli. It is the most prevalent primary glomerular disease worldwide. The exact prevalence of IgA nephropathy varies across different populations and regions.
Studies have shown that the prevalence of IgA nephropathy ranges from 2 to 20 cases per 100,000 individuals. However, it is important to note that these numbers may underestimate the true prevalence as many cases go undiagnosed or are asymptomatic.
The disease is more commonly found in certain ethnic groups, such as Asians and Caucasians, compared to African populations. It also tends to affect males more frequently than females, with a male-to-female ratio of approximately 2:1.
IgA nephropathy is typically diagnosed in young adults, with the peak incidence occurring between the ages of 15 and 35. However, it can affect individuals of all ages, including children and older adults.
Early detection and management of IgA nephropathy are crucial to prevent disease progression and complications. Regular monitoring of kidney function and blood pressure, along with appropriate treatment, can help improve outcomes for individuals with this condition.